Today is: April 17, 2011

Evaluate Your Case Today







Calcagno & Associates

900 South Avenue, 3rd Floor
Staten Island, NY, 10314
Phone: 1-800-WE-FIGHT
             (718) 568-3585


By appointment only

Battery Place
New York, NY, 10004
Phone: (800) 933-4448

Grand Concourse Bronx, NY, 10451 Phone: (718) 933-4448

Bay Parkway Brooklyn, NY, 11214 Phone: (800) 487-6837


Name (First & Last)
DOB (Victims Date of Birth)

Phone

Email Address

Address

City

State

ZipCode

Message about your case

Gardasil

Gardasil, the vaccine that protects girls and women against cervical cancer, was recently linked to a very troubling potential side effect – Guillain-Barre syndrome (GBS), a rare nervous system disorder. The findings of a study presented at the April 2009 annual meeting of the American Academy of Neurology suggest that “some cases [of GBS] are caused by the vaccine,” according to study author Nizar Souayah, MD, of the University of Medicine and Dentistry of New Jersey.

Added to the Routine Immunization Schedule

Manufactured and marketed by the pharmaceutical giant Merck & Co., Gardasil vaccination was added by the U.S. Centers for Disease Control and Prevention (CDC) in early 2007 to the routine childhood immunization schedule that essentially all American children undergo. The Gardasil vaccination is recommended for all girls age 11 to 12, with “catch-up” doses for girls and women from 13 to 26 who haven’t been vaccinated with Gardasil.

Gardasil: An HPV Vaccination

Virtually all cases of cervical cancer (over 99%) are caused by infection with one of several high-risk HPV (human papillomavirus) viruses, and the purpose of the Gardasil vaccine is to prevent these HPV infections. According to The American Cancer Society, about 11,000 women are diagnosed with cervical cancer and approximately 3,800 women die of cervical cancer in the U.S. each year.

As of the end of 2008, over 23 million Gardasil vaccinations had been distributed in the U.S. The recent study’s authors used a CDC- and FDA-managed database – the Vaccine Adverse Event Reporting System (VAERS) – to study the possible post-FDA approval side effects of Gardasil, and they found 53 cases of GBS after HPV vaccinations administered from 2006 to 2008.

In nearly three-quarters of the 53 cases, the disorder developed within six weeks of the vaccination date. In fact, over one third of the cases developed in the first two weeks after the patient was vaccinated.

Merck’s Response

A spokeswoman for Merck & Co. responded to the study findings, stating that “The FDA and CDC have reviewed the reports of GBS that have been submitted to VAERS. To date, there is no evidence that Gardasil has increased the rate of GBS above that expected in the population.”

If You Have Been Injured by Gardasil

Have you or a loved one been injured after taking Gardasil? If so, contact us to speak with one of our experienced Gardasil attorneys who specializes in drug recall litigation & lawsuits. Let us help you win the compensation you need and deserve.

Return to Defective Drugs Listing

 

Keywords | Articles | Locations | Coupons |